Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-32,600.00
% of Total Estimate Gain
-16.48%

James Aggressive Allocation Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, JAMES ADVANTAGE FUNDS held - shares of Novo Nordisk AS(NVO), totaling N/A. This investment constitutes 0% of their stock portfolio, and JAMES ADVANTAGE FUNDS now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2023Q4. And since then James Aggressive Allocation Fund has made 1 purchases of NVO, at an average price of $98.89, for a total of 2,000.00 shares. In addition, there have been 1 sales at an average price of $82.59 for 2,000.00 shares. Based on historical transaction data and NVO's current price of $64.31, James Aggressive Allocation Fund's estimated gain on his NVO holdings is $-32,600.00, reflecting a -16.48% gain to date.

James Aggressive Allocation Fund NVO ($64.31) Holding Chart

James Aggressive Allocation Fund NVO ($64.31) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1